JPRN-UMIN000049623招募中Unknown
Factors associated with treatment responsiveness and treatment course of Parent-Child Interaction Therapy (PCIT) - Factors associated with treatment responsiveness and treatment course of Parent-Child Interaction Therapy (PCIT)
ational Center of Neurology and Psychiatry0 个研究点目标入组 30 人开始时间: 2022年11月30日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2years-old 至 7years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) When medical care other than PCIT is desired by the physician 2) When the child's caregiver has Intellectual Disability. 3) When there is a significant child abuse and immediate social welfare support is desired. 4) Other cases in which the principal investigator deems it difficult to perform the examination 5) Other cases in which the principal investigator determines that PCIT is inappropriate.
研究者
相似试验
已完成
不适用
A Study on predictors of treatment response concerning of the efficacy of tolvaptan on refractory ascites.iver cirrhosis with refractory ascites.JPRN-UMIN000026426The third department of internal medicine, Nara Medical University30
已完成
不适用
An exploratory study of treatment sensitivity and prognostic factors in a Phase III, randomized, controlled study comparing the efficacy and safety of mFOLFOX6 + bevacizumab therapy vs. mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naïve wild-type RAS(KRAS/NRAS) unresectable advanced or recurrent colorectal cancercolorectal cancerJPRN-UMIN000016782Takeda Pharmaceutical Company Limited757
已完成
3 期
An exploratory study of treatment sensitivity and prognostic factors in a efficacy and safety study of mFOLFOX6 + bevacizumab versus mFOLFOX6 + panitumumab therapy in patients with chemotherapy-naive unresectable advanced or recurrent colorectal cancerColorectal cancerJPRN-jRCT1080222785Takeda Pharmaceutical Company Limited757
招募中
不适用
Clinico-biological Data Collection Study of Metastatic Lung CancerLung CancerNCT04944030Institut Cancerologie de l'Ouest200
招募中
不适用
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosisDRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600